Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Sunitinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Itolizumab Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021 4 0
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021 7 1
Theaflavin 3,3'-digallate Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021 3 0
Tilorone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 3 0
Amentoflavone Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 4 0
Vortioxetine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/05/2021 2 0
Excel (.xslx) CSV (.csv)